MedTrace Logo

ACL-R Opioid Sparing Study

NCT06561035 · Status: ENROLLING_BY_INVITATION · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2024-08-19

No results posted yet for this study

Summary

This is a randomized control trial to investigate the effectiveness of a multimodal opiate sparing analgesic regimen in controlling post-operative pain and potentially reduce post-operative opioid consumption in patients undergoing Anterior Cruciate Ligament Reconstruction (ACL-R).

Conditions

  • Anterior Cruciate Ligament Injuries

Interventions

DRUG

Opiate Sparing

Subjects will receive medications in the Opiate Sparing arm for pain control.

DRUG

Opiate Based

Subjects will receive medications in the Opiate Based arm for pain control.

Sponsors & Collaborators

  • Campbell Clinic

    lead OTHER

Principal Investigators

  • Joseph Lamplot, MD · Campbell Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-08-31
Completion
2026-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06561035 on ClinicalTrials.gov